Literature DB >> 9710621

Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.

C L Burke1, D F Stern.   

Abstract

Receptor dimerization is a crucial intermediate step in activation of signaling by receptor tyrosine kinases (RTKs). However, dimerization of the RTK Neu (also designated ErbB-2, HER-2, and p185(neu)), while necessary, is not sufficient for signaling. Earlier work in our laboratory had shown that introduction of an ectopic cysteine into the Neu juxtamembrane domain induces Neu dimerization but not signaling. Since Neu signaling does require dimerization, we hypothesized that there are additional constraints that govern signaling ability. With the importance of the interreceptor cross-phosphorylation reaction, a likely constraint was the relative geometry of receptors within the dimer. We have tested this possibility by constructing a consecutive series of cysteine substitutions in the Neu juxtamembrane domain in order to force dimerization along a series of interreceptor faces. Within the group that dimerized constitutively, a subset had transforming activity. The substitutions in this subset all mapped to the same face of a predicted alpha helix, the most likely conformation for the intramembrane domain. Furthermore, this face of interaction aligns with the projected Neu* V664E substitution and with a predicted amphipathic interface in the Neu juxtamembrane domain. We propose that these results identify an RTK dimer interface and that dimerization of this RTK induces an extended contact between juxtamembrane and intramembrane alpha helices.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710621      PMCID: PMC109122          DOI: 10.1128/MCB.18.9.5371

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  An extra cysteine proximal to the transmembrane domain induces differential cross-linking of p185neu and p185neu.

Authors:  H Cao; L Bangalore; C Dompé; B J Bormann; D F Stern
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

2.  Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.

Authors:  F J Lofts; H C Hurst; M J Sternberg; W J Gullick
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

3.  Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices.

Authors:  M A Lemmon; J M Flanagan; J F Hunt; B D Adair; B J Bormann; C E Dempsey; D M Engelman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

4.  TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.

Authors:  H Cao; S Decker; D F Stern
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

5.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

6.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Authors:  C T Guy; M A Webster; M Schaller; T J Parsons; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Proline in alpha-helix: stability and conformation studied by dynamics simulation.

Authors:  R H Yun; A Anderson; J Hermans
Journal:  Proteins       Date:  1991

8.  Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.

Authors:  N Redemann; B Holzmann; T von Rüden; E F Wagner; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.

Authors:  Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  A subdomain in the transmembrane domain is necessary for p185neu* activation.

Authors:  H Cao; L Bangalore; B J Bormann; D F Stern
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  28 in total

1.  Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.

Authors:  C A Bell; J A Tynan; K C Hart; A N Meyer; S C Robertson; D J Donoghue
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.

Authors:  Joshua T Dilworth; Jonathan W Wojtkowiak; Patricia Mathieu; Michael A Tainsky; John J Reiners; Raymond R Mattingly; Chad N Hancock
Journal:  Cancer Biol Ther       Date:  2008-12-07       Impact factor: 4.742

Review 4.  Transmembrane helix-helix interactions involved in ErbB receptor signaling.

Authors:  Florian Cymer; Dirk Schneider
Journal:  Cell Adh Migr       Date:  2010-04-13       Impact factor: 3.405

5.  Molecular modeling of nearly full-length ErbB2 receptor.

Authors:  Péter Bagossi; Gábor Horváth; György Vereb; János Szöllösi; József Tözsér
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

6.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

7.  Nerve growth factor signals via preexisting TrkA receptor oligomers.

Authors:  Paul S Mischel; Joy A Umbach; Sepehr Eskandari; Shane G Smith; Cameron B Gundersen; Guido A Zampighi
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

8.  The transmembrane domain of Neu in a lipid bilayer: molecular dynamics simulations.

Authors:  Bryan M van der Ende; Frances J Sharom; James H Davis
Journal:  Eur Biophys J       Date:  2004-06-09       Impact factor: 1.733

9.  Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.

Authors:  Xiaochun Yu; Kailash D Sharma; Tsuyoshi Takahashi; Ryo Iwamoto; Eisuke Mekada
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

10.  Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor.

Authors:  Marçal Vilar; Ioannis Charalampopoulos; Rajappa S Kenchappa; Alessandra Reversi; Joanna M Klos-Applequist; Esra Karaca; Anastasia Simi; Carlos Spuch; Soyoung Choi; Wilma J Friedman; Johan Ericson; Giampietro Schiavo; Bruce D Carter; Carlos F Ibáñez
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.